Nirmatrelvir + Ritonavir
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Nirmatrelvir
nirmatrelvir - Ritonavir
ritonavir
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| nirmatrelvir + ritonavirAUES | 150 mg / 100 mg | Pfizer Australia Pty Ltd |
| PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite packAU | 150 mg / 100 mg | Pfizer Australia Pty Ltd |
| ritonavir + nirmatrelvirAU | — | — |
| 倍拉維150毫克/100毫克膜衣錠TW | — | 輝瑞大藥廠股份有限公司 |
| PAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETSSG | 150 mg / 100 mg | PFIZER PRIVATE LIMITED |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · PAXLOVID · 1 products · record
- ES · PAXLOVID · 1 products · record
- MX · PAXLOVID · 1 products · record
- AU · PAXLOVID · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.